The pattern of dyslipidemia among Urban African-Americans with type 2 diabetes

Diabetes Care

Volumn 23, Issue 3, 2000, Pages 319-324

  Cook, Curtiss B ^a   Erdman, Diane M ^b   Ryan, Gina J ^c   Greenlund, Kurt J ^d   Giles, Wayne H ^d   Gallina, Daniel L ^a   El Kebbi, Imad M ^a   Ziemer, David C ^a   Ernst, Kris L ^b   Dunbar, Virginia G ^b   Phillips, Lawrence S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GRADY HEALTH SYSTEM   (United States)

^c MERCER UNIVERSITY   (United States)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE DIFFERENCE; RISK ASSESSMENT; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; URBAN POPULATION;

EID: 17944403144     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.3.319     Document Type: Article

References (28)

1. American Diabetes Association: Diabetes 1996 Vital Statistics. Alexandria, VA, American Diabetes Association, 1996
2. Gu K, Cowie CC, Harris MI: Diabetes and decline in heart disease mortality in US adults. JAMA 281:291-1297, 1999
3. Barrett-Connor E, Grundy SM, Holdbrook MJ: Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol 115: 657-663, 1982
4. Sowers JR, Lester MA: Diabetes and cardiovascular disease. Diabetes Care 22:14-20, 1999
5. Steiner G: Risk factors for macrovascular disease in type 2 diabetes: classic lipid abnormalities. Diabetes Care 22 (Suppl. 3):C6-C9, 1999
6. Laakso M: Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus. Ann Med 28:341-545, 1996
7. Miller M: The epidemiology of triglyceride as a coronary artery disease risk factor. Clin Cardiol 22 (Suppl. 11):111-116, 1999
8. National Cholesterol Education Program: Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Washington, DC: U.S. Govt. Printing Office (NIH publ. no. 93-3095)
9. Harris MI: Hypercholesterolemia in diabetes and glucose intolerance in the U.S. population. Diabetes Care 14:366-374, 1991
10. American Diabetes Association: Management of dyslipidemia in adults with diabetes. Diabetes Care 22 (Suppl. 1):S56-S59, 1999
11. Cowie CC, Howard BV, Harris MI: Serum lipoproteins in African-Americans and whites with non-insulin dependent diabetes in the US population. Circulation 90:1185-1193, 1994
12. Werk EE Jr, Gonzalez JJ, Ranney JE: Lipid level differences and hypertension effect in blacks and whites with type II diabetes. Ethn Dis 3:242-249, 1993
13. Summerson JH, Konen JC, Dignan MB: Racial differences in lipid and lipoprotein levels in diabetes. Metabolism 41:851-855, 1992
14. Ziemer DC, Goldschmid MG, Musey VC, Domin WS, Thule PM, Gallina DL, Phillips LS: Diabetes in urban African Americans. III. Management of type II diabetes in a municipal hospital setting. Am J Med 101: 25-33, 1996
15. Cook CB, Ziemer DC, El-Kebbi IM, Gallina DL, Dunbar VG, Ernst KL, Phillips LS: Diabetes in urban African Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care 22:1494-1500, 1999
16. Kahn HS, Dunbar VG, Ziemer DC, Phillips LS: Diabetes in urban African Americans. XII. Anthropometry for assessing municipal hospital outpatients recently diagnosed with type 2 diabetes. Obes Res 6:247-254, 1998
17. Friedewald WT, Levy RI, Frederickson DS: Estimation of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentifuge. Clin Chem 18:499-502, 1972
18. Pyörälä K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G, the Scandinavian Simvastatin Survival Study (4S): Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary artery disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20:614-620, 1997
19. Aronow WS, Ahn C: Risk factors for new coronary events in older African-American men and women. Am J Cardiol 82:902-904, 1998
20. Stamler J, Vaccaro O, Neaton J, Wentworth D for the Multiple Risk Factor Intervention Trial Research Group: Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16: 434-444, 1993
21. Keil JE, Sutherland SE, Knapp RG, Lackland DT, Gazes PC, Tyroler HA: Mortality rates and risk factors for coronary disease in black as compared with white men and women. N Engl J Med 329:73-78, 1993
22. Gerhard GT, Sexton G, Malinow MR, Wander RC, Connor SL, Pappu AS, Connor WE: Premenopausal black women have more risk factors for coronary heart disease than white women. Am J Cardiol 82:1040-1045, 1998
23. Grundy SM: Statin trials and goals of cholesterol-lowering therapy. Circulation 97: 1436-1439, 1998
24. Cullen P, Assmann G: Treatment goals for low-density lipoprotein cholesterol in the secondary prevention of coronary heart disease: absolute levels or extent of lowering? Am J Cardiol 80:1287-1294, 1997
25. Haffner SM, Lehto S, Rönnemaa T, Pyöräla K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
26. Barrett-Connor E, Wingard DL: Heart disease and diabetes. In Diabetes in America. Washington, DC. U.S. Govt. Printing Office, 1995, p. 429-456 (NIH publ. no. 95-1468)
27. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotem cholesterol: Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 341:410-418, 1999
28. Gaillard TR, Schuster DP, Bossetti BM, Green PA, Osei, K: The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Diabetes Care 20:745-752, 1997